In this article, we discuss 5 small-cap stocks to buy according to Ken Fisher. If you want to read our detailed analysis of Fisher’s investment philosophy, hedge fund returns, and history, go directly to 10 Small-Cap Stocks to Buy According to Ken Fisher.
5. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Fisher Asset Management’s Stake Value: $64.8 million
Percentage of Fisher Asset Management’s Portfolio: 0.03%
Market Cap as of June 16: $1.687 billion
The biotechnology company BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) discovers novel, oral, and small-molecule medicines. On June 8, the company’s drug for the prevention of heterotopic ossification (HO) in patients with fibrodysplasia ossificans progressiva (FOP), BCX9250, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA).
On May 5, Piper Sandler analyst Christopher Raymond maintained an Overweight rating on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) after lowering his price target to $19 to $24.
Out of the 912 hedge funds tracked by Insider Monkey, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was a part of 25 portfolios in the first quarter of 2022. The funds had a total stake worth $458.5 million. In the previous quarter, 19 hedge funds were bullish on the company and had a combined stake value of $412.6 million.
4. Century Aluminum Company (NASDAQ:CENX)
Fisher Asset Management’s Stake Value: $66 million
Percentage of Fisher Asset Management’s Portfolio: 0.03%
Market Cap as of June 16: $921.9 million
Century Aluminum Company (NASDAQ:CENX) is America’s largest producer of primary aluminum. The company doesn’t produce aluminum from aluminum scrap. Instead, it extracts directly from the ore. In the first quarter of 2022, Ken Fisher increased his holding in the company by 5% and was the most significant stakeholder of the company, with a position worth $66 million.
Century Aluminum Company (NASDAQ:CENX) posted its first-quarter 2022 EPS of $0.59, outperforming the estimates by $0.26. The company lagged behind in the revenue estimates by $100,000 after reporting a revenue of $753.60 million.
On May 18, Century Aluminum Company (NASDAQ:CENX) was downgraded to Peer Perform from Outperform and the price target was reduced to $14 from $30 by Wolfe Research analyst Timna Tanners. In recent weeks, the analyst reported that a “sharply worse” power price outlook in the MISO region exceeds a positive aluminum view.
3. Winnebago Industries, Inc. (NYSE:WGO)
Fisher Asset Management’s Stake Value: $90.16 million
Percentage of Fisher Asset Management’s Portfolio: 0.05%
Market Cap as of June 16: $1.446 billion
Winnebago Industries, Inc. (NYSE:WGO) started as a producer of motor homes in 1958. In 2018, the company acquired Chris-Craft Corporation to expand into recreational motor boat manufacturing.
Winnebago Industries, Inc. (NYSE:WGO) is a dividend stock with a 1.56% yield and a P/E ratio of 4.51. Since 2004, the company has increased its quarterly dividend by 1 cent per share each year till 15th June 2021. On August 18, the next quarterly dividend was declared at $0.18, with an increase of 6 cents per share.
2. Yelp Inc. (NYSE:YELP)
Fisher Asset Management’s Stake Value: $101 million
Percentage of Fisher Asset Management’s Portfolio: 0.05%
Market Cap as of June 16: $1.96 billion
Yelp Inc. (NYSE:YELP) is one of Ken Fisher’s most significant small-cap stocks. With a market capitalization of $1.96 billion, the company is approximately $40 million shy of being a mid-cap stock. Fisher Asset Management decreased its activity in the company by 3% in the first quarter of 2022, yet it remains the most significant stakeholder of the company, with a stake worth $101 million.
Yelp Inc. (NYSE:YELP) missed the Q1 EPS estimates of $0.34 by a considerable margin as it posted an EPS of $0.14. However, the company surpassed its revenue estimates by $10.03 million after generating revenues of $276.63 million.
On May 10, Yelp Inc. (NYSE:YELP)’s price target was lowered from $42 to $37 with a Market Perform rating on the shares by BMO Capital analyst Daniel Salmon. In a research note, the analyst added that the company is performing well in executing the ad product roadmap and expanding its self-serve and multi-location businesses. However, its catalysts remain shifty and near-term investment continues.
1. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)
Fisher Asset Management’s Stake Value: $125.7 million
Percentage of Fisher Asset Management’s Portfolio: 0.07%
Market Cap as of June 16: $1.715 billion
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) provides practice management and electronic health record technology to health care providers. According to Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s first-quarter 2022 earnings reports, the diluted EPS of $0.17 shows a 183.33% YoY growth. The revenue of $142.67 million conveys a 6.75% YoY growth. Furthermore, the net income and net profit margin reflected a 152.37% and 136.28% YoY growth, respectively.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) had positive hedge fund sentiment in the first quarter of 2022. It was part of 31 hedge fund portfolios in the first quarter of 2022, compared to 21 in the previous quarter. Ken Fisher had the most significant stake in the company, with 5.58 million shares worth $125.7 million, making up 0.7% of the fund’s portfolio.
You can also peek at 10 Stocks to Buy Now According to Steve Ketchum’s Sound Point Capital and 10 Stocks to Buy in April According to Jim Cramer.
